The test is based on detecting mutations in the telomerase reverse transcriptase (TERT) gene – a crucial element for cancer genesis and progression, the most common mutations in bladder cancer, according to the report by the UN World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) and international partners.
IP: 126.96.36.199. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.